The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
115752452 11575245 2 F 20060814 20160712 20150930 20160720 EXP JP-ASTELLAS-2007JP001997 ASTELLAS KENMOCHI T, ASANO T, SAIGO K, MARUYAMA M, AKUTSU N, IWASHITA C, ET AL.. ADAPTATION AND TREATMENT RESULTS OF LIVING DONOR PANCREAS TRANSPLANTATION FOR SEVERE TYPE I DIABETES MELLITUS. TRANSPLANTATION. 2008;43(S):250 32.00 YR F Y 47.00000 KG 20160720 COUNTRY NOT SPECIFIED JP

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
115752452 11575245 1 PS TACROLIMUS. TACROLIMUS 1 Oral 0.15 MG/KG, ONCE DAILY 50708 .15 MG/KG CAPSULE QD
115752452 11575245 2 SS TACROLIMUS. TACROLIMUS 1 Oral 0.15 MG/KG, ONCE DAILY U 50708 .15 MG/KG CAPSULE QD
115752452 11575245 3 SS TACROLIMUS. TACROLIMUS 1 Intravenous (not otherwise specified) 0.05 MG/KG, ONCE DAILY 0 .05 MG/KG INJECTION QD
115752452 11575245 4 SS TACROLIMUS. TACROLIMUS 1 Unknown UNK UNK, UNKNOWN FREQ. U 0 MODIFIED-RELEASE CAPSULE, HARD
115752452 11575245 5 SS ENDOXAN CYCLOPHOSPHAMIDE 1 Unknown UNK UNK, UNKNOWN FREQ. U 0 FORMULATION UNKNOWN
115752452 11575245 6 C CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Oral U 0 1 G PER ORAL NOS QD
115752452 11575245 7 C CELLCEPT MYCOPHENOLATE MOFETILMYCOPHENOLATE MOFETIL HYDROCHLORIDE 1 Oral U 0 1.5 G PER ORAL NOS QD
115752452 11575245 8 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral U 0 10 MG PER ORAL NOS QD
115752452 11575245 9 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral U 0 40 MG PER ORAL NOS QD
115752452 11575245 10 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral U 0 30 MG PER ORAL NOS QD
115752452 11575245 11 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral U 0 20 MG PER ORAL NOS QD
115752452 11575245 12 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral U 0 10 MG PER ORAL NOS QD
115752452 11575245 13 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Oral U 0 5 MG PER ORAL NOS QD
115752452 11575245 14 C PREDONINE PREDNISOLONEPREDNISOLONE ACETATEPREDNISOLONE SODIUM SUCCINATE 1 Intravenous (not otherwise specified) U 0 50 MG INJECTION QD
115752452 11575245 15 C RITUXAN RITUXIMAB 1 Intravenous drip U 0 200 MG/M**2 INJECTION QD
115752452 11575245 16 C METHYLPREDNISOLONE /00049603/ 2 Intravenous (not otherwise specified) U 0 500 MG INJECTION QD
115752452 11575245 17 C SIMULECT BASILIXIMAB 1 Intravenous (not otherwise specified) U 0 20 MG INJECTION QD
115752452 11575245 18 C SIMULECT BASILIXIMAB 1 Intravenous (not otherwise specified) U 0 20 MG INJECTION QD
115752452 11575245 19 C HEPARIN HEPARIN SODIUM 1 Unknown UNK UNK, CONTINUOUS U 0 FORMULATION UNKNOWN
115752452 11575245 20 C HEPARIN HEPARIN SODIUM 1 Unknown 5000-10000 UNITS, CONTINUOUSLY U 0 FORMULATION UNKNOWN
115752452 11575245 21 C BAYASPIRIN ASPIRIN 1 Unknown U 0 100 MG FORMULATION UNKNOWN QD
115752452 11575245 22 C GABEXATE MESILATE GABEXATE MESYLATE 1 Unknown U 0 600 MG FORMULATION UNKNOWN
115752452 11575245 23 C GABEXATE MESILATE GABEXATE MESYLATE 1 U 0 FORMULATION UNKNOWN
115752452 11575245 24 C OCTREOTIDE. OCTREOTIDE 1 Subcutaneous U 0 100 UG INJECTION Q12H
115752452 11575245 25 C OCTREOTIDE. OCTREOTIDE 1 U 0 INJECTION
115752452 11575245 26 C PIPERACILLIN PIPERACILLIN 1 Intravenous (not otherwise specified) UNK UNK, UNKNOWN FREQ. U 0 INJECTION
115752452 11575245 27 C FLUCONAZOLE. FLUCONAZOLE 1 Intravenous (not otherwise specified) UNK UNK, UNKNOWN FREQ. U 0 INJECTION
115752452 11575245 28 C GANCICLOVIR. GANCICLOVIR 1 Intravenous (not otherwise specified) UNK UNK, UNKNOWN FREQ. U 0 INJECTION
115752452 11575245 29 C GANCICLOVIR. GANCICLOVIR 1 U 0 INJECTION
115752452 11575245 30 C INSULIN ASPART INSULIN ASPART 1 Intravenous (not otherwise specified) U 0 13 IU INJECTION QD
115752452 11575245 31 C INSULIN ASPART INSULIN ASPART 1 Intravenous (not otherwise specified) U 0 9 IU INJECTION QD
115752452 11575245 32 C INSULIN ASPART INSULIN ASPART 1 Intravenous (not otherwise specified) U 0 8 IU INJECTION QD
115752452 11575245 33 C INSULIN GLARGINE INSULIN GLARGINE 1 Unknown U 0 10 IU INJECTION QD

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
115752452 11575245 1 Immunosuppressant drug therapy
115752452 11575245 3 Immunosuppressant drug therapy
115752452 11575245 4 Immunosuppressant drug therapy
115752452 11575245 5 Immunosuppressant drug therapy
115752452 11575245 6 Immunosuppressant drug therapy
115752452 11575245 8 Immunosuppressant drug therapy
115752452 11575245 14 Immunosuppressant drug therapy
115752452 11575245 15 Immunosuppressant drug therapy
115752452 11575245 16 Immunosuppressant drug therapy
115752452 11575245 17 Immunosuppressant drug therapy
115752452 11575245 19 Anticoagulant therapy
115752452 11575245 21 Anticoagulant therapy
115752452 11575245 22 Pancreatic leak
115752452 11575245 23 Prophylaxis
115752452 11575245 24 Pancreatic leak
115752452 11575245 25 Prophylaxis
115752452 11575245 26 Infection prophylaxis
115752452 11575245 27 Infection prophylaxis
115752452 11575245 28 Infection prophylaxis
115752452 11575245 29 Cytomegalovirus test positive
115752452 11575245 30 Type 1 diabetes mellitus
115752452 11575245 33 Type 1 diabetes mellitus

Outcome of event

Event ID CASEID OUTC COD
115752452 11575245 OT

Reactions reported

Event ID CASEID DRUG REC ACT PT
115752452 11575245 Cytomegalovirus test positive
115752452 11575245 Pancreatic leak
115752452 11575245 Pancytopenia
115752452 11575245 Renal impairment

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
115752452 11575245 1 200606 0
115752452 11575245 2 20060712 0
115752452 11575245 3 20060705 20060711 0
115752452 11575245 6 200606 0
115752452 11575245 7 20060706 0
115752452 11575245 8 2006 2006 0
115752452 11575245 9 20060709 20060711 0
115752452 11575245 10 20060712 20060714 0
115752452 11575245 11 20060715 20060717 0
115752452 11575245 12 20060717 20060731 0
115752452 11575245 13 20060801 0
115752452 11575245 14 20060706 20060708 0
115752452 11575245 15 20060621 20060621 0
115752452 11575245 16 20060705 20060705 0
115752452 11575245 17 20060705 20060705 0
115752452 11575245 18 20060709 20060709 0
115752452 11575245 19 20060705 20060705 0
115752452 11575245 20 200607 200607 0
115752452 11575245 21 200607 0
115752452 11575245 22 200607 200607 0
115752452 11575245 24 200607 200607 0
115752452 11575245 26 20060712 20060715 0
115752452 11575245 27 20060712 20060715 0
115752452 11575245 28 20060712 20060715 0
115752452 11575245 30 200607 0
115752452 11575245 33 20060805 0